Pharmafile Logo
Pharmafocus logo
Advanced Search

Astellas Pharma shares positive results from phase 3b trial of Fezolinetant for menopause symptoms

June 28, 2023
Medical Communications Astellas Pharma, Pharmacy, clinical trial, fezolinetant, menopause

Astellas Pharma has announced positive topline results from the phase 3b DAYLIGHT clinical trial for fezolinetant, its investigational oral, nonhormonal …

News

Bristol Myers Squibb’s Sotyktu recommended for NHS use for adult patients with psoriasis

June 28, 2023
Medical Communications Dermatology, NHS, Sotyktu, bristol myers squibb, psoriasis

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has recommended Sotyktu (deucravacitinib) …

News
national-cancer-institute-kluafqlacfw-unsplash

UK nonprofit National Cancer Research Institute to close

June 27, 2023
Medical Communications Cancer, NCRI, National Cancer Research Institute, Oncology, oncology

The National Cancer Research Institute (NCRI) has announced that it is closing after 22 years of advancing cancer research. Established …

News
markus-spiske-dnbtfbnqlrc-unsplash_1

GSK receives FDA Fast Track designation for novel gonorrhoea vaccine

June 27, 2023
Research and Development FDA, GSK, Infections and infestations, Vaccine, fast track designation, gonorrhoea

GSK has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for its investigational vaccine …

News
volodymyr-hryshchenko-m1hq4ibp9rc-unsplash

AstraZeneca’s Xigduo XR approved in China for adults with type-2 diabetes

June 27, 2023
Medical Communications AstraZeneca, China, Diabetes, Xigduo XR, diabetes

AstraZeneca has announced that its Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily fixed-dose combination, has now been approved …

News
lungs

Verona Pharma submits FDA New Drug Application for COPD treatment

June 27, 2023
Research and Development COPD, Cardiology, FDA, ensifentrine, new drug application, verona pharma

UK-based Verona Pharma has announced that it has submitted a New Drug Application (NDA) to the US Food and Drug …

News
blood-1813410_960_720

Sanofi shares data about new drug for haemophilia A in paediatric patients

June 26, 2023
Research and Development Haematology, Sanofi, clinical trial, haemophilia a

Sanofi has shared new data from the phase 3 XTEND-Kids study which assessed Altuviiio (Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein) …

News

FDA approves Pfizer’s Litfulo for patients with severe alopecia areata

June 26, 2023
Medical Communications FDA, Litfulo, Pfizer, Pharmacy, alopecia, alopecia areata

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its Litfulo (ritlecitinib) for patients over the …

News

AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation

June 26, 2023
Medical Communications AstraZeneca, CHMP, EMA, Immunology, soliris

UK-based biopharmaceutical company AstraZeneca has announced that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) …

News

CHMP gives positive opinion recommending authorisation to GSK’s CKD drug

June 26, 2023
Medical Communications CKD, EMA, Nephrology

Global biopharmaceutical company GSK has announced that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) …

News
dna-1903319_960_720

Cartesian Therapeutics announces successful trial of RNA cell therapy in autoimmunity

June 23, 2023
Research and Development Cartesian Therapeutics, Neurology, RNA, autoimmune, neurology

Clinical stage biotechnology company, Cartesian Therapeutics, has announced results from its clinical trial using RNA CAR T (rCAR T) therapy …

News
study_participant_receives_niaid-gsk_candidate_ebola_vaccine

Moderna files for FDA authorisation for updated COVID-19 vaccine

June 23, 2023
Research and Development COVID-19, FDA, Immunology, Moderna, Vaccine

Biotechnology company Moderna has announced that it has completed submission of a regulatory application to the US Food and Drug …

News

XOMA acquires royalty and milestone rights for NPC and pancreatic cancer assets

June 23, 2023
Sales and Marketing Cancer, Oncology, Xoma, acquisition, oncology

US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …

News
money-pills-pharma-file

GSK settles first Zantac lawsuit due for trial in US

June 23, 2023
Medical Communications Cancer, GSK, Pharmacy, Zantac, lawsuit

UK-based pharmaceutical and biotechnology company GSK has reached a settlement with a US man who claims the drugmaker’s heartburn medicine …

News
inhaler-2520472_960_720

Lupin Healthcare launches Beclu carbon neutral inhalers for asthma treatment

June 22, 2023
Research and Development Asthma & COPD, Beclu, Lupin Healthcare, asthma, carbon neutral, inhaler

UK-based subsidiary of Lupin Limited, Lupin Healthcare, has announced the UK launch of its carbon neutral pressurised metered dose inhalers …

News

FDA approves new medicines to treat paediatric type 2 diabetes

June 22, 2023
Medical Communications Diabetes, FDA, Synjardy, jardiance, paediatrics, type 2 diabetes

The US Food and Drug Administration (FDA) has announced that it has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin …

News

Hyloris enrols first patient in four-arm clinical trial

June 22, 2023
Research and Development Genito-Urinary system, Hyloris, bladder pain, clinical trial, cystitis

Belgian specialty biopharmaceutical company Hyloris has announced that it has enrolled the first patient in its four-arm interstitial cystitis/bladder pain …

News
money_pills_2

Zymeworks to open new EU HQ in Dublin, Ireland

June 22, 2023
Business Services Dublin, Oncology, Zymeworks, headquarters, regulatory affiars

Canadian biotech company Zymeworks has announced plans to open its new Clinical and Regulatory EU headquarters in Dublin, Ireland. Zymework …

News

Eli Lilly to acquire DICE Therapeutics for immunology innovations

June 21, 2023
Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology

Eli Lilly and DICE Therapeutics have announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company focusing on …

News
mufid-majnun-cm1au42fnrg-unsplash_3

GSK shares positive data for RSV vaccine

June 21, 2023
Research and Development GSK, Immunology, RSV, Vaccine, clinical trial

GSK have announced new positive data from the AReSVi-006 phase 3 trial which assessed the efficacy of a single dose …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025